Published in:
01-04-2020 | Thrombocytopenia | Case Report
Severe fever with thrombocytopenia syndrome (SFTS) treated with a novel antiviral medication, favipiravir (T-705)
Published in: Infection | Issue 2/2020
Login to get accessAbstract
Background
Severe fever and thrombocytopenia syndrome (SFTS) is an acute illness with a high mortality (16.2–29.1%). Unfortunately, there is no specific cure or vaccine for SFTS.
Methods
In this open-label study, two patients with SFTS were treated with favipiravir, a new antiviral drug.
Results
Patients had a sustainable virologic, immunologic and symptomatic recovery.
Conclusions
Favipiravir may be a prosiming drug for the treatment of SFTS.